Yixiang Li, PhD

Dr. Li is a postdoctoral fellow focused on understanding how modulation of epigenetic modifiers in SCLC impacts its neuroendocrine phenotype and the consequences of this on tumor immunogenicity. His work utilizes single cell approaches using in vivo immunocompetent mouse models. He is originally from China and attended Emory University for his PhD where he did his thesis work in Dr. Jin-Tang Dong's laboratory working on drug resistance in prostate cancer. He joined the Oser laboratory in October 2020.